Sermorelin

This material is provided for controlled laboratory research and analytical characterization only.

Sermorelin binds to and activates the growth hormone-releasing hormone receptor (GHRHR) on somatotroph cells in the anterior pituitary gland. Somatotrophs are specialized for the synthesis and secretion of growth hormone (GH), a 191-amino acid peptide hormone involved in regulating growth and metabolism.

Downstream Effects of GH

Once released, GH exerts effects by binding to its receptor (GHR) in various tissues. This activates signaling pathways such as JAK-STAT and MAPK cascades. Many of GH's effects are also mediated indirectly through the production of insulin-like growth factor-1 (IGF-1), primarily in the liver. The GH/IGF-1 axis is a key regulator of processes such as protein synthesis, lipolysis, cell proliferation, and bone metabolism.

Age-related changes in the GH/IGF-1 axis have been documented in scientific literature.

Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

Laboratory Handling

Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

Research Limitations

Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.